During the past decade, Reid Health conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 185 clinical trials were completed, i.e. on average, 142.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 66 clinical trials were completed. i.e. 178.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reid Health" #1 sponsor was "National Cancer Institute (NCI)" with 144 trials, followed by "Alliance for Clinical Trials in Oncology" with 85 trials sponsored, "SWOG Cancer Research Network" with 78 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "NRG Oncology" with 25 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reid Health" #1 collaborator was "National Cancer Institute (NCI)" with 222 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Reid Health" are "Breast Cancer" (32 trials), "Lymphoma" (21 trials), "Lung Cancer" (17 trials), "Recurrent Breast Carcinoma" (13 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials). Many other conditions were trialed in "Reid Health" in a lesser frequency.

Most popular intervention types in "Reid Health" are "Drug" (317 trials), "Other" (199 trials), "Biological" (151 trials), "Procedure" (74 trials) and "Radiation" (55 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (90 trials), "Quality-of-Life Assessment" (60 trials), "Paclitaxel" (36 trials), "Carboplatin" (35 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.

The vast majority of trials in "Reid Health" are 314 trials for "All" genders, 54 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Reid Health". undefined are not yet recruiting, 58 are recruiting, 118 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 164 completed trials in Reid Health, 3 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Reid Health, 10 "Phase 1" clinical trials were conducted, 196 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".